10th week of 2010 patent applcation highlights part 48 |
Patent application number | Title | Published |
20100063212 | USE OF POLYPROPYLENE HAVING CHAIN BRANCHING TO BROADEN THE PROCESSING WINDOW IN THE INJECTION STRETCH BLOW MOLDING - Use of polypropylene having long chain branching to broaden the processing window in the injection stretch blow moulding of at least one propylene polymer. | 2010-03-11 |
20100063213 | GEL-PROCESSED POLYOLEFIN COMPOSITIONS - Semicrystalline polyolefins with narrow molecular weight distributions characterized by a low polydispersity index (PDI) and selected from the families of homopolymers, statistical copolymers, block copolymers, and graft copolymers, can be blended with a low molecular weight fluid diluent to create gel fiber and film compositions. These gel compositions, when subjected to mechanical or thermomechanical processing, either before or after removal of the diluent, result in fiber or film compositions that combine high tensile strength with other desirable physical properties, such as high rigidity, large extension at break, and/or high recoverable elasticity. These desirable combinations of properties are superior to those obtained from gel-processed semicrystalline polyolefins that are substantially similar in composition and molecular weight, but that have large PDIs. | 2010-03-11 |
20100063214 | PROCESS FOR PRODUCING FLUORINATION-TREATED PERFLUOROPOLYMER - To provide a process for efficiently producing a perfluoropolymer having unstable terminal groups reduced. | 2010-03-11 |
20100063215 | CURABLE COMPOSITION - The present invention has its object to provide a curable composition not containing any organotin type curing catalyst currently of concern because of the toxic feature thereof, or any volatile compound, excellent in curability and storage stability and, further, capable of providing cured products excellent in strength and elongation; the above object can be achieved by a curable composition which includes: an organic polymer (A) containing a hydrolyzable silyl group in a molecule; an amidine compound (B); and a compound (C) containing a sulfonyl group in a molecule. | 2010-03-11 |
20100063216 | PROCESS FOR THE ELIMINATION OF RESIDUAL MERCAPTANS FROM NITRILE RUBBERS - Process for the elimination of residual mercaptans from nitrile rubbers, comprising:
| 2010-03-11 |
20100063217 | FLAME-RETARDANT ADHESIVE RESIN COMPOSITION AND ADHESIVE FILM USING THE SAME - Disclosed is a halogen- and phosphorus-free flame-retardant adhesive resin composition which can be used in heat contact bonding of adherends at or below 250° C. and is excellent in heat resistance, solder heat resistance after moisture absorption, and processability. Also disclosed is an adhesive film produced from said composition. The flame-retardant adhesive resin composition comprises 65-98% by weight of a silicone unit-containing polyimide resin and 2-35% by weight of an epoxy resin having an acenaphthylene-substituted naphthalene skeleton. The adhesive film produced from the flame-retardant adhesive resin composition is suitable as an adhesive for a laminate for a multiplayer printed circuit board substrate, an adhesive for a hybrid circuit board substrate, and an adhesive for a coverlay film. | 2010-03-11 |
20100063218 | NON-TEXTILE POLYMER COMPOSITIONS AND METHODS - Included are nylon and polyurethane urea compositions such as in the form of powders, beads and flock to be included in extruded and molded articles containing a thermoplastic resin such as nylon 12. The addition of the powders, beads or flock improve flexibility and shape retention of such molded articles, for example in eyewear frames. | 2010-03-11 |
20100063219 | AROMATIC POLYESTER RESIN COMPOSITION AND PROCESS FOR PRODUCTION THEREOF - An aromatic polyester resin composition, comprising: a melt-kneaded product of 99-70 weight parts of an aromatic polyester resin and 1-30 wt. parts (providing a total of 100 wt. parts together with the aromatic polyester resin) of a polyglycolic acid resin, wherein the composition is characterized by a transesterification rate C | 2010-03-11 |
20100063220 | COATING COMPOSITION - Coating composition comprising one or more polythiols, one or more polyisocyanates, and a base compound, e.g., an amine catalyst, and a carboxylic acid compound, e.g., cyanoacetic acid and/or a halogenated acetic acid, such as dichloroacetic acid or trifluoroacetic acid. The molar ratio of the acid compound to the basic compound is preferably at least 2:1, e.g. at least 10:1. | 2010-03-11 |
20100063221 | POLYSILOXANE COMPOSITION - A polysiloxane composition having high transparency, while being excellent in heat resistance and light resistance is provided. | 2010-03-11 |
20100063222 | FLUORINE-CONTAINING POLYMER AND RESIN COMPOSITION - A polymer containing: a constitutional unit A that is derived from fluorosilsesquioxane having one addition polymerizable functional group in a molecule; a constitutional unit B that is derived from organopolysiloxane having an addition polymerizable functional group; and a constitutional unit C that is derived from an addition polymerizable monomer and has a group having a polymerizable unsaturated bond on a side chain, and optionally containing a constitutional unit D that is derived from an addition polymerizable monomer other than the fluorosilsesquioxane having one addition polymerizable functional group in a molecule, the organopolysiloxane having an addition polymerizable functional group and the addition polymerizable monomer having a functional group capable of introducing a group having a polymerizable unsaturated bond. | 2010-03-11 |
20100063223 | COPOLYMER GRAFTED WITH POLYAMIDE, MATERIAL COMPRISING IT, PREPARATION PROCESS AND USES - The invention relates to a graft copolymer composed of a block copolymer of general formula B-(A) | 2010-03-11 |
20100063224 | APPARATUS AND METHOD FOR PRODUCING POLYOLEFIN | 2010-03-11 |
20100063225 | Polymer synthetic technique - The present invention generally relates to methods for the synthesis of species including monomers and polymers. Methods of the invention comprise the use of chemical techniques including metathesis chemistry to synthesize, for example, monomers and/or polymers with desired functional groups. | 2010-03-11 |
20100063226 | NORBORNENE-BASED POLYMER HAVING LOW DIELECTRIC CONSTANT AND LOW-LOSS PROPERTIES, AND INSULATING MATERIAL, PRINTED CIRCUIT BOARD AND FUNCTION ELEMENT USING THE SAME - The present invention relates to a to a norbornene-based polymer having a low dielectric constant and low-loss properties, and an insulating material, a printed circuit board and a functional device using the same. More particularly, it relates to a norbornene-based polymer expressed by the following formula (1): | 2010-03-11 |
20100063227 | CATALYST SYSTEMS AND POLYMERIZATION PROCESSES - A method of polymerizing olefins with catalyst systems, such as, for example, a multimodal catalyst system, wherein the catalyst system is stored at a controlled temperature to minimize loss of catalyst system productivity. | 2010-03-11 |
20100063228 | TRANSITION METAL COMPLEX, PROCESS FOR PRODUCING THE SAME, AND USE - A transition metal complex of the following formula (1): | 2010-03-11 |
20100063229 | Polymerisation of Ethylene and Alpha-Olefins with Pyrrol-Iminophenol Complexes - The present invention relates to the field of single site catalyst systems based on pyrrol-iminophenol, pyrrol-iminoalcohol or pyrrol-iminoamine complexes and suitable for oligomerising or homo- or co-polymerising ethylene and alpha-olefins. | 2010-03-11 |
20100063230 | CATALYST COMPONENTS BASED ON FERRICINIUM COMPLEXES USED FOR OLEFIN POLYMERISATION - The present invention discloses catalyst components based on ferricinium ligands, their method of preparation and their use in the polymerisation of olefins. | 2010-03-11 |
20100063231 | HYPERBRANCHED MALEIC ANHYDRIDE-DIENE POLYMERS - A hyperbranched polymer having pendent olefinic groups and comprising polymer units derived from one or more terminally-unsaturated, acyclic aliphatic diene and polymer units derived from maleic anhydride. Optionally, the hyperbranched polymer may further comprise polymer units derived from one or more 1-alkenes and/or a chain transfer agent. A process to prepare the hyperbranched polymer comprises contacting maleic anhydride with at least one terminally unsaturated acyclic aliphatic diene having at least 7 carbon atoms in the presence of an effective amount of a radical initiator in an aprotic solvent under dilute conditions. | 2010-03-11 |
20100063232 | POLYMERIZABLE SULFONIC ACID ONIUM SALT AND RESIN - A resin that includes a repeating unit shown by the following formula (10) has an excellent performance as a radiation sensitive acid generator, and exhibits only a small adverse effect on the environment and a human body. | 2010-03-11 |
20100063233 | Method for producing acrylic acid - There is provided a novel process for producing acrylic acid by which acrylic acid can be obtained from a raw material independent of petroleum. The process for producing acrylic acid according to the present invention comprises the steps of: applying a dehydration reaction to glycerol as a raw material in a gas phase; and then applying a gas phase oxidation reaction to a gaseous reaction product formed by the dehydration reaction. | 2010-03-11 |
20100063234 | METHOD FOR PRODUCTION OF POLYSTER RESIN FILM, AND POLYESTER RESIN FILM, ANTIREFLECTIVE FILM AND DIFFUSION FILM PRODUCED BY THE METHOD - One aspect of the present invention provides a method for production of a polyester resin film comprising melt extruding a polyester resin into a sheet shape, cooling and solidifying the polyester resin sheet on a casting drum, then longitudinally stretching the polyester resin sheet in a longitudinal direction, and then passing the longitudinally stretched polyester resin film through a transverse stretching apparatus to transversely stretch the longitudinally stretched polyester resin film in a transverse direction, wherein Xc, Tc, Ts and Te satisfy the formulas of: | 2010-03-11 |
20100063235 | POLYMER CRYSTALLINE MATERIALS - One embodiment of the present invention provides polymer crystalline materials containing crystals of the polymer and satisfying the following requirements (I) and (II) or the following requirements (I) and (III): (I) the polymer crystalline materials a crystallinity of 70% or greater; (II) the crystals are 300 nm or less in size; and (III) the crystals have a number density of 40 μm | 2010-03-11 |
20100063236 | Catalyst for Dealcoholization Condensation Reaction and Method for Producing Organopolysiloxane Using the Same - In the present invention, when an organopolysiloxane is produced by a dealcoholization condensation reaction between a silicon atom-bonded hydroxy group and a silicon atom-bonded alkoxy group, a quaternary ammonium ion-containing compound such as an alkylammonium hydroxide compound or a silanolate thereof is used as a catalyst. The catalyst for the dealcoholization condensation reaction of the present invention is easily removed after use and is stable. For this reason, when an organopolysiloxane is produced using the aforementioned catalyst, it is not necessary to use complicated production steps or a large amount of the catalyst. | 2010-03-11 |
20100063237 | Hydrophilic Surface Modification of Polydimethylsiloxane - A method for the preparation of hydrophilic elastomers involves the synthesis of polydimethylsiloxane with tunable hydrophilic surface properties. An elastomeric monolith with desired hydrophilic properties is produced by combining a polyethylene oxide polymeric surfactant additive with a PDMS base and curing agent during polymerization. The surfactant chain segment lengths are varied to control the hydrophobic/hydrophilic balance. | 2010-03-11 |
20100063238 | ISOCYANATE TRIMER MODIFIED WITH SILANE OR POLYSILOXANE AND METHOD OF PREPARAING THE SAME - An isocyanate trimer modified with silane or functional polysiloxane and having formula of | 2010-03-11 |
20100063239 | POLYIMIDE RESIN - A polyimide resin represented by the following general formula (I): | 2010-03-11 |
20100063240 | Novel Thermoplastic Hydrogel Polymer Compositions For Use In Producing Contact Lenses And Methods Of Producing Said Compositions - The present invention relates generally to production of thermoplastic materials which swell in water to produce hydrogels. These materials will hereafter be referred to as “thermoplastic hydrogels”. They are useful as contact lenses or for use in vision correction prosthetics or as cosmetic devices. In particular, the invention relates to thermoplastic hydrogels which show improved flow characteristics. | 2010-03-11 |
20100063241 | HIGH PERFORMANCE POLYASPARTIMIDE RESIN - New polyaspartimide compositions and methods of forming and using those compositions arc provided. The compositions are formed by reacting a bismaleimide and diamine in a solvent-free environment. The resulting polyaspartimide comprising recurring monomers of | 2010-03-11 |
20100063242 | PREPARATION AND USES OF POLYARYLATES - The present invention is directed to polyarylates comprising repeating units having the structure: | 2010-03-11 |
20100063243 | POLYAMIC ACIDS, POLYIMIDES, AND PROCESSES FOR THE PRODUCTION THEREOF - To provide polyamic acids and polyimides, which have high light transmittance and heat resistance such that their thermal decomposition temperatures are at least 300° C. and which are excellent in their solubility in solvents and have their processability improved. | 2010-03-11 |
20100063244 | POLYMERIC COATING FOR PROTECTING OBJECTS - A protective polymeric coating is applied to the surface of various objects which are to be exposed to a harsh environment. The protective polymeric coating covers the exposed surface, where the polymeric coating includes a polyimide polymer. The polyimide polymer in the polymeric coating has a backbone with at least one non-terminal phenyl group. A linkage is connected to the non-terminal phenyl group, where the linkage can be an amide linkage or an ester linkage. An oligomeric silsesquioxane compound is connected to the linkage through an organic substituent, where the oligomeric silsesquioxane is not incorporated into the polymer backbone. The polymeric coating provides protection to the underlying object. | 2010-03-11 |
20100063245 | Semi-Crystalline Semi-Aromatic Polyamide - The invention relates to a semi-crystalline semi-aromatic polyamide comprising A-A-B-B units derived from (a) dicarboxylic acids consisting of a mixture of aromatic dicarboxylic acid and aliphatic dicarboxylic acid and (b) diamines consisting of a mixture of long chain aliphatic diamine and short chain aliphatic diamine, wherein (a-i) the aromatic dicarboxylic acid consists for at least 80 mole % of terephthalic acid, and (a-ii) the aliphatic dicarboxylic acid constitutes at least 5 mole % of the dicarboxylic acids, (b-i) the short chain aliphatic diamine constitutes at least 10 mole % of the diamines, and (c) the aromatic dicarboxylic acid and the long chain aliphatic diamine constitute 60-90 mole % of the total molar amount of dicarboxylic acids and diamines. | 2010-03-11 |
20100063246 | POLYMERIZABLE COMPOSITION, RESIN USING THE SAME, OPTICAL COMPONENT AND LENS - Disclosed is a polymerizable composition containing a compound represented by the general formula (1) below and a bluing agent,
| 2010-03-11 |
20100063247 | CHLORINATED VINYL CHLORIDE-BASED RESIN AND MANUFACTURING METHOD - An object of the present invention is to provide a chlorinated vinyl chloride-based resin with few unstable structures and excellent thermal stability, and a molding article. The chlorinated vinyl chloride-based resin of the invention is an resin in which a chlorine content is 65 wt % or higher, and less than 69 wt %, —CCl | 2010-03-11 |
20100063248 | A NEW INDUSTRIALLY VIABLE METHOD FOR THE PRODUCTION OF POLYCARBYNES, POLYMERIC PRECURSORS TO DIAMOND AND DIAMOND LIKE CERAMICS - This invention is related to a new method of synthesizing polycarbynes. These polymers are known to produce diamond and diamond like ceramics upon heating, by plasma processing, and chemical vapour deposition. | 2010-03-11 |
20100063249 | PROTON-CONDUCTING COMPOUND AND PROTON-CONDUCTING POLYMER - Provided is a proton-conducting compound which provides proton conductivity without humidification and is suitable for electrochemical device materials such as solid electrolytes for fuel cells and electrolytes for batteries. Provided also is a proton-conducting polymer. The proton-conducting compound is composed of a melamine compound salt obtained from a melamine compound represented by the following formula (1) and a Bronsted acid and the proton-conducting polymer is obtained by homopolymerizing or copolymerizing the melamine compound salt. In formula (1), R | 2010-03-11 |
20100063250 | TRUNCATED TAU PROTEINS - Described are novel N- and C-terminally double truncated tau molecules, (“type IA, IB, IIA and IIB tau molecules”) as well as methods for providing these molecules, both from recombinant and biological sources. Moreover, screening methods using these molecules in connection with Alzheimer's diagnosis and therapy are provided. | 2010-03-11 |
20100063251 | COMPOSITIONS AND METHODS FOR TREATMENT OF CHRONIC FATIGUE SYNDROME AND NEURODEGENERATIVE DISEASES - The present invention relates to use of pharmaceutical formulations of a-MSH for the treatment of chronic fatigue syndrome and neurodegenerative diseases. | 2010-03-11 |
20100063252 | PROCESSES AND INTERMEDIATES - The invention relates to compounds and processes useful for the preparation of protease inhibitors, particularly serine protease inhibitors. The protease inhibitors are useful for treatment of HCV infections. | 2010-03-11 |
20100063253 | Long-Lasting Collagen and Manufacturing Method thereof - In a long-lasting collagen and its manufacturing method, a pig skin is gone through processes of scraping extra tissues, removing fats, imbibition, digesting, centrifugal separation, salting-out, collecting lower-layer precipitate and freeze-drying to form a collagen, and the collagen is mixed with γ-PGA, and then a glutaraldehyde solution is added and mixed uniformly to perform a first crosslinking and form the long-lasting collagen, so as to overcome the shortcomings of a conventional collagen having a short storage time, a requirement of applying the collagen repeatedly, and a high concentration of remained glutaradldehyde which is biologically poisonous to human bodies. | 2010-03-11 |
20100063254 | PROCESS FOR OBTAINING LEGUME PROTEIN FRACTIONS OF MODERATE MOLECULAR WEIGHT, LEGUME PROTEIN FRACTIONS AND USE THEREOF - A process for producing coagulated leguminous protein fractions of MW>14, comprising: initial charging of fruit juice; coagulation of the leguminous protein; removal of a leguminous protein fraction whose majority has an MW of from >14 kD to approx. 600 kD; optionally, washing the coagulated leguminous protein fraction thus obtained; and optionally, drying the leguminous protein fraction, and to the use of the leguminous protein fraction as a food, food additive, medicament additive, animal feed, in cosmetics, as industrial protein, and/or as an adhesive. | 2010-03-11 |
20100063255 | Canola Protein Isolate Compositions - A new canola protein isolate is provided along with a new canola protein. The new canola protein isolate is obtained from the supernatant from the production of a canola protein micellar mass and contains a predominance of 2S protein. The canola protein isolate derived from PMM contains a predominance of a 7S protein. Compositions of the canola protein isolate are provided. | 2010-03-11 |
20100063256 | Novel immunoglobulin-binding proteins with improved specificity - The present invention relates to modified immunoglobulin-binding proteins, e.g., | 2010-03-11 |
20100063257 | Purification of FC-TACI Fusion Proteins Using the Oilbody Technology - The invention relates to a process for the purification of Fe-fusion proteins such as TACI-Fc using genetically engineered oilbodies expressing protein A. | 2010-03-11 |
20100063258 | FUSION PROTEIN CONSTRUCTS - Polypeptide linkers with defined tertiary structures, usually of defined alpha helical structure, are used to join two domains in a fusion protein. In one embodiment of the invention, a method is provided for the cell-free synthesis of the fusion protein. | 2010-03-11 |
20100063259 | Compositions and methods for diagnosing or treating psoriasis - The present invention provides nucleic acid molecules, polypeptides, antibodies and methods for the diagnosis and/or treatment of psoriasis. | 2010-03-11 |
20100063260 | Whitefly Ecdysone Receptor Antibody - The present invention relates to a novel isolated whitefly ecdysone receptor polypeptide. The invention also relates to an isolated nucleic acid encoding the whitefly ecdysone receptor polypeptide, to vectors comprising them and to their uses, in particular in methods for modulating gene expression in an ecdysone receptor-based gene expression modulation system and methods for identifying molecules that modulate whitefly ecdysone receptor activity. | 2010-03-11 |
20100063261 | Affinity chromatography matrices and methods of making and using the same - The invention provides methods of coupling protein ligands to a solid support. The invention also provides affinity chromatography matrices and methods of using affinity chromatography matrices to purify a target molecule. | 2010-03-11 |
20100063262 | PROCESS FOR PRODUCING 5-AMINOPYRAZOLE DERIVATIVE, AND AZO DYE - A process for producing a 5-aminopyrazole derivative represented by Formula (I) includes a step of reacting a hydrazine compound represented by Formula (II) with a compound represented by Formula (III) under a condition satisfying Reaction Condition 1 and Reaction Condition 2, wherein
| 2010-03-11 |
20100063263 | Magnetic particles with a closed ultrathin silica layer, method for the production thereof and their use - The invention relates to magnetic particles coated with silica (Si02), whereby the silicate layer is closed and tight and is characterized by having an extremely small thickness on the scale of a few nanometers—hereafter also referred to as a silica nanolayer. This invention also relates to an improved method for producing these silicate-containing magnetic particles that, in comparison to the prior art, lead to a product having a closed silicate layer and thus entail a highly improved purity. In addition, the novel method prevents an uncontrolled formation of aggregates and clusters of silicates on the magnetite surface, thereby having a positive influence on the properties and biological applications cited below. The novel method also enables the depletion of nanoparticulate solid substance particles on the basis of a fractionated centrifugation. The inventive magnetic particles exhibit an optimized magnetization and suspension behavior as well as a very advantageous run-off behavior from plastic surfaces. These highly pure magnetic particles coated with silicon dioxide are preferably used for isolating nucleic acids from cell and tissue samples, whereby the separating out from a sample matrix ensues by means of magnetic fields. These particles are particularly well suited for the automatic purification of nucleic acids, mostly from biological body samples for the purpose of analyzing them with different amplification methods. | 2010-03-11 |
20100063264 | NUCLEOTIDE SEQUENCING VIA REPETITIVE SINGLE MOLECULE HYBRIDIZATION - Methods of obtaining sequence information about target oligonucleotides by repetitive single molecule hybridization are disclosed. The methods include exposing a target oligonucleotide to one or more copies of a test oligonucleotide; measuring hybridization; dehybridizing the test oligonucleotide; and repeating until the information content from the hybridization trials equals or exceeds the information content of the target oligonucleotide. | 2010-03-11 |
20100063265 | CORN EVENT 3272 AND METHODS OF DETECTION THEREOF - A novel transgenic corn event designated 3272, is disclosed. The invention relates to DNA sequences of the recombinant constructs inserted into the corn genome that resulted in the 3272 event and of genomic sequences flanking the insertion sites as well as to assays for detecting the presence of the 3272 event based on these novel sequences. The invention further relates to seeds of corn plants comprising the 3272 genotype, to corn plants comprising the genotype of 3272 and to methods for producing a corn plant by crossing a corn plant comprising the 3272 genotype with itself or another corn variety. | 2010-03-11 |
20100063266 | Method for Isolating Both Free and Protein Association DNA - A method is disclosed for isolating both free and protein-associated DNA from bodily fluids, such as urine, saliva, serum, tears, sweat, cerebral spinal fluid, and plasma. The method comprises as a first step concentrating and isolating both the free DNA and the proteins present in the bodily fluid. The proteins are then disgested in order to release the formerly protein-associated DNA from the isolated proteins. Lastly, the free and formerly protein-associated DNA can be isolated and purified. | 2010-03-11 |
20100063267 | BI-FUNCTIONAL COMPOUND POSITIVELY CHARGED AT FIRST PH AND NEGATIVELY CHARGED AT SECOND PH, SOLID SUPPORT COMPRISING THE BI-FUNCTIONAL COMPOUND, AND METHOD OF ISOLATING NUCLEIC ACID USING THE SAME - Provided are a bi-functional compound that is positively charged at a first pH and negatively charged at a second pH, a solid support having the bi-functional compound immobilized thereon, and a method of isolating a nucleic acid, including: binding the bi-functional compound with a nucleic acid at a first pH and isolating the nucleic acid from the bi-functional compound at a second pH. | 2010-03-11 |
20100063268 | NUCLEIC ACID EXTRACTION METHOD - A method for extracting a nucleic acid, which comprises: (a) preparing a biomaterial containing a solution by a following step (i) or (ii): (i) a step in which a biomaterial containing a phosphate buffer solution or a Bis-Tris (N,N-bis(2-hydroxyethyl)iminotris(hydroxymethyl)methane) buffer solution is prepared; or (ii) a step in which a buffer solution contained in a biomaterial is replaced with a Bis-Tris buffer solution; (b) dissolving the biomaterial with a lysis solution, and eluting a nucleic acid contained in the biomaterial; (c) preparing a lysate solution by adding a water-soluble organic solvent to the nucleic acid-eluted solution obtained in the step (b); (d) allowing the nucleic acid contained in the lysate solution to be adsorbed by a solid material; (e) washing impurities remaining in the solid material and the lysis solution; and (f) desorbing the absorbed nucleic acid from the solid material by a recovering solution. | 2010-03-11 |
20100063269 | PROCESS FOR REDUCING THE AVERAGE MOLECULAR WEIGHT OF CELLULOSE ETHERS - A process for reducing the average molecular weight of a cellulose ether comprises the step of contacting a cellulose ether with an acid to partially depolymerize it to a lower molecular weight in a diluent comprising at least 50 weight percent of an organic hydroxylic compound having at least one hydroxy group and at least two carbon atoms. | 2010-03-11 |
20100063270 | Purification of Streptococcal Capsular Polysaccharide - A purification process for the capsular polysaccharide of | 2010-03-11 |
20100063271 | SUPERCRITICAL FLUID BIOMASS CONVERSION SYSTEMS - Disclosed herein are supercritical fluid biomass conversion machines, systems, and methods for converting a wide range of biomass materials into a plurality of reaction products including fermentable sugars and various aromatic substances. In one embodiment, a method is disclosed that comprises the steps of: providing an extruder; conveying a mixture of the selected biomass material and water through the extruder and into a supercritical fluid biomass conversion zone; heating and further pressurizing the mixture within the supercritical fluid biomass conversion zone to yield at least supercritical water, wherein heat energy is supplied by means of an induction heating coil positioned circumferentially about the supercritical fluid biomass conversion zone; retaining the mixture within the supercritical fluid biomass conversion zone for a period of time sufficient to yield the plurality of reaction products; and separating the plurality of reaction products into at least a water soluble fraction and an organic solvent soluble fraction. | 2010-03-11 |
20100063272 | METHOD FOR PRODUCING STEROID COMPOUND - It is an object of the present invention to provide a novel method for producing a steroid compound. The present invention provides a method for producing 5β-3,7-dioxocholanic acid or an ester derivative thereof, using, as a raw material, a sterol having double bonds at position 5 and at position 24, such as cholesta-5,7,24-trien-3β-ol, ergosta-5,7,24(28)-trien-3β-ol, desmosterol, fucosterol, or ergosta-5,24(28)-dien-3β-ol, via the following 4 steps: | 2010-03-11 |
20100063273 | NOVEL CRYSTAL OF PIPERACILLIN SODIUM - Disclosed are a novel crystal of piperacillin sodium which has diffraction angles of 3.7°, 5.5°, 7.3°, 11.6°, 14.5° and 18.0° and a novel crystal of piperacillin sodium which has diffraction angles of 5.6°, 7.8°, 12.3°, 15.5°, 17.5°, 23.3°, 24.8° and 28.5° expressed by 2θ in the powder X-ray diffraction analysis. The crystals have excellent stability and solubility and a low water-absorbing property, is extremely easy to be handled in the manufacturing process for a medicinal substance and in the packing during the preparation process for a pharmaceutical product. A pharmaceutical preparation for injection comprising any one of the crystals is useful. | 2010-03-11 |
20100063274 | METHOD FOR PREPARING AMIDE - The present invention provides a method for preparing amides, in which an amino acid ionic liquid is used as both a reaction medium and a catalyst to catalyze Beckman rearrangement of a ketoxime, so as to produce an amide. In the method, the rearrangement is conducted by catalyzing a ketoxime with an amino acid ionic liquid having the asymmetric property at a moderate reaction temperature during a short reaction time, so as to produce an amide without adding other catalysts such as concentrate sulfuric acid. The method has advantages such as avoiding corrosion in equipments with pipelines, the high conversion rate of ketoximes and the high selectivity of amides. | 2010-03-11 |
20100063275 | PROCESS FOR PREPARING 6-PHENOXYPYRIMIDIN-4-OL DERIVATIVES IN THE PRESENCE OF A QUINUCLIDINE OR A N-METHYL PYRROLIDINE DERIVATIVES - The present invention relates, inter alia, to a process for preparing a compound of formula (I): using a quinuclidine-based catalyst or an optionally 3-substituted N-methyl pryrrolidine-based catalyst. | 2010-03-11 |
20100063276 | USE OF 10-[(3R)-1-AZABICYCLO[2.2.2]OCT-3-YLMETHYL]-10H-PHENOTHIAZINE FOR THE PREPARATION OF A DRUG HAVING A SELECTIVE INHIBITION OF MUSCARINIC M1, M2, AND M3 RECEPTORS - This invention relates to the use of 10-[(3R)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10H-phenothiazine as well as its pharmaceutically acceptable salts for the preparation of a drug having the particularity of treating or preventing urinary incontinence, by local and/or oral route. | 2010-03-11 |
20100063277 | Intramolecular C-H amination with sulfonyl azides - Cobalt (II) complexes of porphyrins are effective catalysts for intramolecular nitrene insertion of C—H bonds with arylsulfonyl azides. The cobalt-catalyzed process can proceed efficiently under mild and neutral conditions in low catalyst loading without the need of other reagents or additives, generating nitrogen gas as the only byproduct. Using the simple tetraphenylporphyrin (TPP) as the ligand, the cobalt-catalyzed intramolecular amidation can be applied to primary, secondary, and tertiary C—H bonds and suitable for a broad range of arylsulfonyl azides, leading to the syntheses of various benzosultam derivatives in excellent yields | 2010-03-11 |
20100063278 | N-Formyl Hydroxylamines compounds - Novel N-formyl hydroxylamine compounds and their derivatives are discloses. These N-formyl hydroxylamine compounds inhibit peptidyl deformylase (PDF), an enzyme present in prokaryotes. The compounds are useful as antimicrobials and antibiotics. The compounds of the invention display selective inhibition of peptidyl deformylase versus other metalloproteinases such as MMPs. Methods of preparation and use of the compounds are also disclosed. | 2010-03-11 |
20100063279 | METHOD FOR PRODUCING QUINOLONE CARBOXYLIC ACID DERIVATIVE - The present invention relates to a method for producing a quinolone compound having high antibacterial activity and high safety, at high yield and in a simple manner. | 2010-03-11 |
20100063280 | PROCESS FOR PREPARING CCR-5 RECEPTOR ANTAGONISTS UTILIZING 4-SUBSTITUTED 1-CYCLOPROPANE-SULFONYL-PIPERIDINYL COMPOUNDS - The present invention discloses a novel process to prepare 4-substituted 1-Cyclopropane-sulfonyl-Piperidinyl compounds, which are useful intermediates for the preparation of antagonists of CCR5 receptor and therefore useful for the treatment of HIV virus infected mammals. It specifically discloses a novel process to synthesize 4-[4-[(R)-[1-[cyclopropylsulfonyl)-4-piperidinyl](3-fluorophenyl)methyl]-3(S)-methyl-1-piperazinyl]-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4-methylpiperidine] compounds. | 2010-03-11 |
20100063281 | DIPHENYL AMINE DERIVATIVES HAVING LUMINESCENCE PROPERTY - The present invention relates to diphenyl amine derivatives having luminescent properties, and particularly to diphenyl amines substituted with various electron-donating or electron-withdrawing groups. The compounds of the present invention show blue or blue-green luminescence, and luminescence of the compounds herein can be achieved by UV or visible light, thus being useful as a fluorescent dye or fluorescent material for an organic electroluminescence device or display. | 2010-03-11 |
20100063282 | Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions, and Uses Thereof - Compounds of Formula (I) | 2010-03-11 |
20100063283 | PROCESS FOR STEREOSELECTIVE SYNTHESIS OF LAMIVUDINE - A process for stereoselective synthesis of lamivudine, comprising (a) glycosylation of compounds of formula (I) and cytosine or protected cytosine, separating the resulting products by crystallization to afford intermediates of formula (II); (b) removing the protecting groups of intermediates of formula (II) to obtain lamivudine. | 2010-03-11 |
20100063284 | SOLID FORMS OF 1-ethyl-3-(5-(5-FLUOROPYRIDIN-3-YL)-7-(PYRIMIDIN-2-YL)-1H-BENZO[D]IMIDAZO- L-2-YL)UREA - Solid forms of crystalline1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1H-benzo[d]imidazol-2-yl)urea, compositions containing solid forms of crystalline1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1H-benzo[d]imidazol-2-yl)urea and methods of using the same are described. | 2010-03-11 |
20100063285 | ANTIFUNGAL TRIAZOLE DERIVATIVES, METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME - The present invention relates to triazole derivaties, a method for the preparation thereof, and a pharmaceutical composition containing the same as an active ingredient. The inventive triazole derivaties have an excellent antifungal activity against various pathogens. | 2010-03-11 |
20100063286 | PIPERAZINYL-PROPYL-PYRAZOLE DERIVATIVES AS DOPAMINE D4 RECEPTOR ANTAGONISTS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME - The present invention relates to a novel piperazinyl-propyl-pyrazole derivative, a method of its preparation and a pharmaceutically acceptable composition comprising the same. The novel piperazinyl-propyl-pyrazole derivative of the present invention has superior selective affinity for dopamine D4 receptor, can effectively inhibit psychotic behavior (cage climbing) induced by apomorphine, and has relatively low adverse effects in mouse rotarod test. Therefore, it can be developed as a therapeutic agent for the treatment and prevention of central nervous system (CNS) disorders, in particular, schizophrenia, attention deficit hyperactivity disorder, depression, stress diseases, panic disorder, phobia, obsessive-compulsive disorder, posttraumatic stress disorder, cognitive disorder, Alzheimer's disease, Parkinson's disease, anxiety, paraphrenia, mania, seizure disorder, personality disorder, migraine, drug addiction, alcohol addiction, obesity, eating disorder, and sleeping disorder. | 2010-03-11 |
20100063287 | PROCESS FOR PREPARING 2-AMINO-5-CYANOBENZOIC ACID DERIVATIVES - Disclosed is a method for preparing a compound of Formula 1 comprising (1) contacting a compound of Formula 2, with (2) at least one alkali metal cyanide and (3) at least one compound of Formula 4 | 2010-03-11 |
20100063288 | PREPARATION OF PIGMENT RED 149 - The invention provides a process for preparing N,N′-di(3′,5′-dimethylphenyl) perylenebis(dicarboximide) by reaction of perylene-3,4,9,10-tetracarboxylic dianhydride with 3,5-dimethylaniline in the presence of a secondary or tertiary amine as catalyst, which comprises effecting the reaction in an aqueous reaction medium and in the presence of added seed crystals of N,N′-di(3′,5′-dimethylphenyl) perylenebis(dicarboximide). | 2010-03-11 |
20100063289 | METHOD FOR PRODUCING AMMONIUM HEXAFLUOROPHOSPHATES - The invention relates to a method for producing ammonium hexafluorophosphates of general formula (1) wherein R | 2010-03-11 |
20100063290 | Preparation of 3,4-Dihydroisoquinolines from an Acid and an Amine - The present invention is directed to processes for the synthesis of morphinans. In particular, a process for coupling a carboxylic acid compound with an amine compound to form an amide product that can then be isolated or the crude amide product can be cyclized to form a 3,4-dihydroisoquinoline. In one embodiment, the carboxylic acid contains a phenol moiety protected with a labile protecting group. The protected phenol reduces reaction times, simplifies work-up of the product, and reduces the amount of cyclizing agent, POCl | 2010-03-11 |
20100063291 | PROCESS FOR PREPARATION OF SOLID MONTELUKAST - A process for preparation of montelukast or a salt thereof is provided, the process including reacting a late intermediate compound which is 2-[1-[1-R-3-[2-(7 chloro quinolin-2-yl)vinyl [phenyl]-3-[2-methoxy carbonyl phenyl]propyl sulfonyl methyl]cyclo propyl]acetic acid or a salt thereof with methyl magnesium chloride or methyl magnesium bromide in an organic solvent. In one embodiment, the process includes reacting an earlier intermediate compound which is methyl 2-(3-R-(3-(2-(7-chloro 2-quinolinyl)-ethenyl)-3 hydroxy propyl)benzoate with methane sulfonyl chloride or toluene sulfonyl chloride to obtain a mesylated or tosylated derivative of the earlier intermediate compound; followed by a reaction of the mesylated or tosylated derivative with 1-mercapto methyl cyclopropane acetic acid in a polar solvent in a presence of a base to obtain the late intermediate compound. | 2010-03-11 |
20100063292 | PROCESS FOR THE PREPARATION OF TRIFLUOROETHOXYTOLUENES. - The present invention relates to an process for the preparation 2,5-bis(2,2,2-trifluoroethoxy)toluene [II]. The compound 2,5-bis(2,2,2-trifluoroethoxy)toluene is useful as intermediate for pharmaceutical industry, especially useful as an intermediate for the preparation of Flecainide and pharmaceutically acceptable salts. | 2010-03-11 |
20100063293 | PROCESS FOR PRODUCING ANTHRANILAMIDE COMPOUND - To provide a process for producing a specific anthranilamide compound or its salt. | 2010-03-11 |
20100063294 | ALCOHOL PRODUCTION METHOD BY REDUCING ESTER OF LACTONE WITH HYDROGEN - Provided is an alcohol production method comprising the step of reducing an ester or a lactone with hydrogen to produce a corresponding alcohol without addition of a base compound by using, as a catalyst, a ruthenium complex represented by the following general formula (1): | 2010-03-11 |
20100063295 | PRIMARY EXPLOSIVES - The present invention provides a compound of the formula (Cat) | 2010-03-11 |
20100063296 | COMPOSITION FOR TREATING INFECTIOUS DISEASES CAUSED BY HELICOBACTER - The invention relates to a compound of general formula (I) for use in a pharmaceutical composition for treating infectious diseases caused by | 2010-03-11 |
20100063297 | PROCESSES FOR THE PREPARATION OF 1,2,4-OXADIAZOLE BENZOIC ACIDS - Provided herein are processes for the preparation of compounds useful for the treatment, prevention or management of diseases associated with a nonsense mutation. More specifically, provided herein are processes for the synthesis of 1,2,4-oxadiazoles. In particular, provided herein are processes useful for the preparation of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid. | 2010-03-11 |
20100063298 | 11C-LABELED BENZOPHENONE/BENZOXAZOLE ANALOGUES AS AN INFLAMMATION IMAGING AGENT - A method of preparing novel [ | 2010-03-11 |
20100063299 | Process for Preparing Irbesartan - Disclosed herein is an improved, commercially viable and industrially advantageous process for the preparation of Irbesartan, or a pharmaceutically acceptable salt thereof, in high yield and purity. | 2010-03-11 |
20100063300 | BIOCATALYTIC PROCESSES FOR THE PREPARATION OF SUBSTANTIALLY STEREOMERICALLY PURE FUSED BICYCLIC PROLINE COMPOUNDS - The present disclosure provides substantially enantiomerically pure heterobicyclic compounds of the following structural formulas, | 2010-03-11 |
20100063301 | SYNTHESIS OF THROMBOPOIETIN ACTIVITY MODULATING COMPOUNDS - Disclosed herein are various methods for synthesizing compounds that modulate thrombopoietin activity. Also disclosed are intermediates useful for the preparation of these compounds. | 2010-03-11 |
20100063302 | CYCLIC SULFONIUM SALT, METHOD FOR PRODUCTION OF CYCLIC SULFONIUM SALT, AND GLYCOSIDASE INHIBITOR - Disclosed are: kotalanol which has an inhibitory activity on a glucosidase; a method for producing kotalanol or a cyclic sulfonium salt which is an analogue to kotalanol by an organic synthesis technique; a cyclic sulfonium salt produced by the method; a glucosidase inhibitor comprising the compound; an anti-diabetic agent or an anti-diabetic food comprising the glucosidase inhibitor. A sulfonium compound including kotalanol can be produced by coupling a thio-sugar synthesized from D-xylose (e.g., a compound having a cyclic structure composed of 4 carbon atoms and one sulfur atom, such as 1,4-dideoxy-1,4-epithio-D-arabinitol) with a heptitol cyclic sulfate ester having a protected hydroxyl group and synthesized from a pentose (D-xylose, D-ribose, D-arabinose, D-lyxose, L-xylose, L-ribose, L-arabinose or L-lyxose) to produce a cyclic sulfonium salt having a protected hydroxyl group, and then deprotecting the hydroxyl group. | 2010-03-11 |
20100063303 | THERAPEUTIC COMPOUNDS - Compound having the formula below are disclosed herein: formula (I). Therapeutic methods, compositions, and medicaments related thereto are also disclosed. | 2010-03-11 |
20100063304 | APPARATUS FOR AUTOMATIC CATALYST EXCHANGE IN A REACTOR WITH A BUNDLE OF CATALYST TUBES - What is proposed is an apparatus for automatic catalyst exchange in a plurality of process steps in the catalyst tubes of a reactor with a bundle of catalyst tubes, which are welded in or rolled in between an upper tube plate and a lower tube plate in longitudinal direction of the reactor, and welded tight, | 2010-03-11 |
20100063305 | METHOD OF PRODUCING S-(-)-6-HYDROXY-2,5,7,8-TETRAMETHYLCHROMANE-2-CARBOXYLIC ACID AND PRODUCT OBTAINED BY THE METHOD - The present invention provides an industrially available method for efficiently producing high-purity S-(−)-6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid excellent in solid-liquid separability from an S-(−)-6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid ester, and also provides products obtained by the method. | 2010-03-11 |
20100063306 | Alkylene oxide recovery systems - Systems and processes for recovering alkylene oxide, including an alkylene oxide recovery column including a stripping section located in the column to convert a portion of a feed stream to a gas phase including alkylene oxide; a reabsorption section in the column above the stripping section including a water stream to reabsorb the alkylene oxide in the gas phase portion and to produce an aqueous solution, a first stripping gas to strip carbon dioxide and oxygen from the aqueous solution by converting a portion of the aqueous solution to a gaseous portion, producing an alkylene oxide stream, and a side take-off located at a bottom portion of the reabsorption section for removal of the alkylene oxide stream; a condenser to partially condense the gas phase portion; and a top take-off for removal of a light impurity fraction. | 2010-03-11 |
20100063307 | PARICALCITOL PURIFICATION - Paricalcitol, a synthetic vitamin D analog, is purified to a purity greater than 99.7% by crystallization from solution in isopropyl acetate solvent, followed by filtration and vacuum drying. Isopropyl acetate appears to be unique among commonly available and pharmaceutically acceptable solvents in its ability to precipitate paricalcitol in this high purity, essentially free of isomers thereof. In addition, paricalcitol of purity of at least 99.9% has been shown to have exceptional storage stability. | 2010-03-11 |
20100063308 | LIPID NANOPARTICLE BASED COMPOSITIONS AND METHODS FOR THE DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES - The present invention relates to novel cationic lipids, transfection agents, microparticles, nanoparticles, and short interfering nucleic acid (siNA) molecules. The invention also features compositions, and methods of use for the study, diagnosis, and treatment of traits, diseases and conditions that respond to the modulation of gene expression and/or activity in a subject or organism. Specifically, the invention relates to novel cationic lipids, microparticles, nanoparticles and transfection agents that effectively transfect or deliver biologically active molecules, such as antibodies (e.g., monoclonal, chimeric, humanized etc.), cholesterol, hormones, antivirals, peptides, proteins, chemotherapeutics, small molecules, vitamins, co-factors, nucleosides, nucleotides, oligonucleotides, enzymatic nucleic acids, antisense nucleic acids, triplex forming oligonucleotides, 2,5-A chimeras, dsRNA, allozymes, aptamers, decoys and analogs thereof, and small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules, to relevant cells and/or tissues, such as in a subject or organism. Such novel cationic lipids, microparticles, nanoparticles and transfection agents are useful, for example, in providing compositions to prevent, inhibit, or treat diseases, conditions, or traits in a cell, subject or organism. The compositions described herein are generally referred to as formulated molecular compositions (FMC) or lipid nanoparticles (LNP). | 2010-03-11 |
20100063309 | BIODIESEL PROCESSES IN THE PRESENCE OF FREE FATTY ACIDS AND BIODIESEL PRODUCER COMPOSITIONS - Glyceride-containing feed for a base catalyzed transesterification with lower alkanol to make biodiesel is pretreated with glycerin separated during the transesterification to partially convert glycerides with lower alkanol contained in the separated glycerin using base catalyst in the separated glycerin while reducing the free fatty acid and phosphorus compound concentrations in the glyceride-containing feed. Unique producer compositions are provided by the pretreatment processes. | 2010-03-11 |
20100063310 | Functionalized silicon compounds - A process for preparing a functionalized carbo-silicon compound comprising contacting, in the presence of a hydrosilation catalyst and under hydrosilation promoting conditions: a hydrolyzable silicon reactant having at least one Si—H functional group, and a functionalized olefin reactant containing at least one terminal olefin functional group and a tertiary carbon atom to which is bonded a second functional methyl group or functional carbon group characterized by having substantial potential to impede a hydrosilation reaction when otherwise not attached to the tertiary carbon atom. | 2010-03-11 |
20100063311 | OLIGOMERIC PHOSPHONATE COMPOSITIONS, THEIR PREPARATION AND USES - This invention provides oligomeric hydrogen phosphonates represented by the formula (I) where R is an alkyl group having one to about six carbon atoms; R′ is a linear or branched hydrocarbylene group or an oxygen-containing hydrocarbylene group having two to about twenty carbon atoms or a hydrocarbylene group having at least one cycloaliphatic or aromatic ring, where at least one of R′ is a linear or branched hydrocarbylene group or an oxygen-containing hydrocarbylene group and at least one of R′ is a hydrocarbylene group having at least one cycloaliphatic or aromatic ring; and n is a number from 2 to about 20. Also provided are processes for making these oligomeric hydrogen phosphonates, oligomeric organophosphonate compositions, and processes for making these oligomeric organophosphonate compositions. | 2010-03-11 |